Rhythm (Nasdaq: IRTC) today shared new findings supporting the use of its long-term continuous monitoring (LTCM) service.

NEW ORLEANS, Louisiana — What if you could have your doctor at your side 24 hours a day, making sure your heart was not causing any health problems? Well now, thanks to technology, that is a reality.

Real-world data across more than 1 million patients published in Heart Rhythm show that 24–48-hour monitoring can miss actionable arrhythmias and ...

Cardiologs, a company that uses ECG data to detect potential cardiac arrhythmias, is developing a new way to predict atrial fibrillation. On Tuesday, the European Heart Journal – Digital Health ...

There is a critical need for non-invasive solutions to monitor heart failure progression around the clock. This novel wearable device is based on sensors embedded in a lightweight belt that monitors ...

Austin, Texas, United States, October 28th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...

This week the FDA has approved a new smartphone ECG device that is capable of detecting three heart arrhythmias takes the form of the AliveCor KardiaMobile. Designed to detect Atrial Fibrillation ...

Samsung has announced that its ECG app for their Galaxy Watch 3 and Galaxy Watch Active 2 has received FDA approval in the USA. Samsung has said that the new electrocardiogram tool will soon be ...

Rogbid has officially announced its new flagship health-focused smartwatch, the Rowatch 10, for 2025. It aims to deliver an enhanced wellness experience by combining robust design and advanced health ...